|
Volumn 8, Issue 6 SUPPL., 2001, Pages 94-101
|
Sarcoma
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
CYTOKINE;
CYTOSTATIC AGENT;
CYTOTOXIC AGENT;
DOXORUBICIN;
IFOSFAMIDE;
IMATINIB;
METHOTREXATE;
NONSTEROID ANTIINFLAMMATORY AGENT;
SULINDAC;
TAMOXIFEN;
VINBLASTINE;
VINCA ALKALOID;
CANCER ADJUVANT THERAPY;
CANCER CLASSIFICATION;
CANCER DIAGNOSIS;
CANCER INCIDENCE;
CANCER LOCALIZATION;
CANCER MORTALITY;
CANCER PALLIATIVE THERAPY;
CANCER RECURRENCE;
CANCER STAGING;
CANCER SURGERY;
CLINICAL TRIAL;
CONFERENCE PAPER;
DESMOID TUMOR;
DIGESTIVE SYSTEM CANCER;
HUMAN;
PRACTICE GUIDELINE;
RETROPERITONEAL SARCOMA;
SARCOMA;
SOFT TISSUE SARCOMA;
UNITED STATES;
ADJUVANT CHEMOTHERAPY;
ADJUVANT THERAPY;
FIBROMATOSIS;
GASTROINTESTINAL TUMOR;
LIMB;
PATHOLOGY;
RECURRENT DISEASE;
RETROPERITONEAL TUMOR;
RISK FACTOR;
TREATMENT OUTCOME;
CHEMOTHERAPY, ADJUVANT;
EXTREMITIES;
FIBROMATOSIS, AGGRESSIVE;
GASTROINTESTINAL NEOPLASMS;
HUMAN;
NEOPLASM STAGING;
RADIOTHERAPY, ADJUVANT;
RECURRENCE;
RETROPERITONEAL NEOPLASMS;
RISK FACTORS;
SARCOMA;
TREATMENT OUTCOME;
|
EID: 0035515878
PISSN: 10732748
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
Times cited : (12)
|
References (19)
|